MERCK SHARP & DOHME LLC: $2.0B Department of Health and Human Services Contract Vehicle
Summary
Merck & Co., Inc. ($MRK) has been awarded a $2.0B contract by the CDC for the Vaccines for Children program. This represents a significant revenue stream for Merck's vaccine business, amounting to roughly 3.3% of its annual revenue. The indefinite delivery/indefinite quantity contract provides multi-year visibility for Merck's top line.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Merck ($MRK) secured a $2.0B CDC contract for the Vaccines for Children program, representing ~3.3% of its annual revenue.
- 2.The IDIQ contract structure provides multi-year revenue stability for Merck's vaccine segment.
- 3.Investors should monitor Merck's vaccine margins and potential supply chain benefits for companies like Sartorius ($STR) and Thermo Fisher ($TMO).
Market Implications
This contract reinforces Merck's leadership in the vaccine market and provides a predictable revenue stream. For a company with thin net margins, this contract could improve overall profitability. The multi-year nature of the IDIQ contract reduces earnings uncertainty for $MRK. Supply chain companies in the vaccine manufacturing ecosystem, such as Sartorius ($STR) and Thermo Fisher ($TMO), may see increased orders for bioprocessing equipment and consumables. However, the impact on Merck's stock price will depend on the contract's margin profile and execution. Investors should watch for future obligations under this IDIQ contract to gauge the full revenue potential.
Full Analysis
The Department of Health and Human Services, through the Centers for Disease Control and Prevention, has awarded a $2.0B indefinite delivery/indefinite quantity contract to Merck Sharp & Dohme LLC for the Vaccines for Children program. This program provides vaccines to children at no cost, and Merck is a key supplier. The award is a direct contract to Merck's subsidiary, making it a clear beneficiary.
Merck & Co., Inc. ($MRK) is the parent company, with FY2025 revenue of $60.1B and net income of $365M. The $2.0B contract represents approximately 3.3% of annual revenue, a meaningful addition that will support Merck's vaccine segment. Given Merck's thin net margin of 0.61% in FY2025, this contract could have a disproportionate impact on profitability if margins on this contract are higher than average.
No specific legislation was identified as directly authorizing this contract, but the Vaccines for Children program is a long-standing federal program. The contract may be funded through annual HHS appropriations. There are no directly related bill signals in the database.
Supply chain beneficiaries include subcontractors that provide vaccine ingredients, manufacturing equipment, and logistics. Key suppliers to Merck's vaccine production include companies like Sartorius ($STR) for bioprocessing equipment and Thermo Fisher Scientific ($TMO) for lab supplies and services. These companies may see downstream demand from increased production.
Historically, large CDC vaccine contracts provide stable, multi-year revenue for pharmaceutical companies. For example, previous VFC contracts have supported consistent growth for vaccine manufacturers. This award reinforces Merck's position in the pediatric vaccine market and provides long-term visibility for investors.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Direct award under the Vaccines for Children program
Who must act
Department of Health and Human Services / Centers for Disease Control and Prevention awarding to Merck Sharp & Dohme LLC
What happens
$2.0B added to contract backlog, representing approximately 3.3% of Merck's annual revenue ($60.1B in FY2025)
Stock impact
Merck's vaccine portfolio, including products like Gardasil and others, will benefit from this multi-year contract. The company's vaccine segment is a key growth driver, and this award solidifies its position in the CDC's Vaccines for Children program.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
HELP Copays Act
MERCK SHARP & DOHME LLC: $156M Department of Health and Human Services Contract
Wildlife Health Coordination and Zoonotic Disease Prevention Act of 2026
A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.
A bill to provide for digital communication of prescribing information for drugs (including biological products), and for other purposes.
A bill to require regulatory review of pharmaceutical products from Chinese entities, and for other purposes.
A bill to impose mandatory minimum sentences for conspiracy to smuggle biological agents into the United States and for making false statements to Federal agents in connection with such smuggling, and for other purposes.
A bill to require continued participation by the United States in the World Health Organization, and for other purposes.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Advancing Women's Health to Improve Outcomes in All Phases of Life
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
Enhancing Program Integrity and Integrity and Interagency Coordination in the Administration of the H-1B Nonimmigrant Visa Program
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
Accelerating Access To Veterans' Benefits And Employment Opportunities
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Contract Details
Recipient
MERCK SHARP & DOHME LLC
Award Amount
$2,046,235,664
Awarding Agency
Department of Health and Human Services
Sub-Agency
Centers for Disease Control and Prevention
Contract Type
INDEFINITE DELIVERY / INDEFINITE QUANTITY
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →